Financial Ratios

VYSALI PHARMACEUTICALS LTD.

NSE : NABSE : 524290ISIN CODE : INE153G01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE4.280 (0 %)
PREV CLOSE ( ) 4.28
OPEN PRICE ( ) 4.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )4.28 4.72
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2009Mar2008Jun2007Mar2006Mar2005
Operational & Financial Ratios
   Earnings Per Share (Rs)-5.81-19.75-1.06-9.27-9.04
   CEPS(Rs)-4.90-19.06-0.25-8.63-8.40
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-4.051.7721.54-25.50-16.22
   Tax Rate(%)-2.17-0.19-1.53-0.210.00
Margin Ratios
   Core EBITDA Margin(%)-154.04-216.20-3.63-96.04-61.57
   EBIT Margin(%)-190.81-222.98-2.71-88.45-63.44
   Pre Tax Margin(%)-256.06-278.49-5.20-92.62-67.67
   PAT Margin (%)-261.63-279.02-5.28-92.82-67.67
   Cash Profit Margin (%)-220.42-269.21-1.27-86.39-62.86
Performance Ratios
   ROA(%)-18.17-47.16-2.94-34.31-25.49
   ROE(%)0.00-169.470.000.000.00
   ROCE(%)-18.61-48.50-2.01-48.93-31.72
   Asset Turnover(x)0.070.170.560.370.38
   Sales/Fixed Asset(x)0.060.190.770.720.96
   Working Capital/Sales(x)-0.27-1.342.041.480.89
Efficiency Ratios
   Fixed Capital/Sales(x)16.975.381.311.391.04
   Receivable days166.98142.2646.24130.54137.34
   Inventory Days150.03360.82235.63571.72600.30
   Payable days1328.03152.64164.49228.77110.54
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.00-0.36
   Price/Book(x)0.000.000.000.00-0.19
   Yield(%)0.00
   EV/Net Sales(x)16.214.981.415.203.25
   EV/Core EBITDA(x)-10.50-2.17100.94-5.98-5.31
   EV/EBIT(x)-8.23-2.07-48.57-5.55-4.91
   EV/CE(x)1.160.970.532.211.31
   M Cap / Sales0.000.000.000.000.24
Growth Ratio
   Net Sales Growth(%)-67.25-64.8398.42-26.54-12.56
   Core EBITDA Growth(%)77.97-5878.63103.19-4.62-77.71
   EBIT Growth(%)73.14-2808.5293.86-4.27-67.68
   PAT Growth(%)70.57-1767.3488.59-2.58-14.36
   EPS Growth(%)70.57-1767.3488.59-2.58-14.36
Financial Stability Ratios
   Total Debt/Equity(x)-6.1612.910.88-1.53-2.39
   Current Ratio(x)0.110.432.031.792.60
   Quick Ratio(x)0.050.290.700.260.67
   Interest Cover(x)-2.92-4.02-1.09-21.18-14.98
   Total Debt/Mcap(x)12.83

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.